DSA 34 Drugs for Motor Disease and Muscle Spasticity Flashcards
which drugs are used for dopamine replacement therapy?
levodopa, carbidopa
which anti-Parkinson’s drugs are direct agonists?
pramipexole, ropinirole
which anti-Parkinson’s drug is a COMT inhibitor?
entacapone
which anti-Parkinson’s drugs are antimuscarinics?
biperiden, trihexyphenidyl, benztropine
which anti-Parkinson’s drugs are MAO-B inhibitors?
selegiline, rasagiline
what is the mechanism of action of amantidine?
increases dopamine availability by increasing dopamine release and decreasing dopamine reuptake
which drugs used to treat myasthenia gravis are immunosuppressants?
azathioprine, cyclosporine, intravenous immunoglobulin
which drugs used to treat myasthenia gravis are anticholinesterases?
pyridostigmine, neostigmine
list the CNS spasmolytics.
baclofen, diazepam, tizanidine, riluzole, gabapentin, metaxalone
what class of drug is dantrolene?
PNS spasmolytic
which class of anti-Parkinson’s drugs primarily help with tremors but not bradykinesia?
anti-ACh agents
what is thought to cause the symptoms of Parkinsonism?
loss of dopamine inhibition → cholinergic excitation → symptoms of Parkinsonism
what primarily occurs in Huntington’s chorea?
GABAergic loss in the indirect pathway → loss of inhibition of thalamic activity
fill in the blank: ACh __ (>/<) DA → Parkinson’s. akinesia, tremors, rigidity.
ACh > DA
fill in the blank: ACh ___ DA (>/<) → Huntington’s. dyskinesia, choreiform movements
ACh < DA
what is the intended target for drug therapy in Parkinsonism?
nigrostrial system
what is the mechanism of action of antipsychotics? result of this action?
block DA receptors, can produce Parkinsonism and/or dystonias
why is L-DOPA not initially used in the treatment of Parkinson’s?
it has about a 5 year window of effectiveness
what is the typical strategy for the treatment of Parkinson’s?
start with MAO-B inhibitor and/or dopaminergic agonist
what is the primary isoenzyme responsible for the degradation of DA in the striatum?
MAO-B
what is a benefit of MAO-B inhibitors not affecting degradation of catecholamines in other brain regions or in the periphery?
little risk of hypertensive crisis due to accumulation of peripheral NE
what causes insomnia as a side effect for MAO-B inhibitors?
amphetamine and methamphetamine metabolites
identify: this drug’s best documented use is as an adjunctive agent to improve response to levodopa.
selegiline
why should selegiline not be given to patients taking TCAs or SSRIs?
danger for serotonin syndrome (profound sympathetic activity with hyperthemia)
why should non-selective MAOIs not be used in Parkinsonism?
would lead to hypertensive crisis when combined with L-DOPA therapy
explain how dopamine agonists have nausea/vomiting as significant untoward effect.
they stimulate D2 receptors
identify: dopamine agonist that affects D3 receptors.
pramipexole
what is the mechanism of action of anticholinergics?
centrally-acting competitive inhibitors of muscarinic cholinergic receptors
which symptom(s) of Parkinson’s is not improved by anticholinergics?
bradykinesia
what are classic side effects of anticholinergics?
dry mouth, urinary retention, constipation
what are contraindications for the use of anticholinergic agents?
prostatic hyperplasia
obstructive GI disease
glaucoma
identify: giving this class of drug will worsen dementia in patients with age- or Parkinson’s-related dementia.
anticholinergics
what are side effects of amantidine?
insomnia, restlessness, depression, GI disturbances, ataxia, livedo reticularis